AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Precision Navigation to Improve Community Cancer Screening Participation

RecruitingNAAges 45 Years - 74 YearsAllHunan Cancer Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study will evaluate whether a precision navigation intervention can help community residents at high risk for cancer complete recommended cancer screening. The study will be conducted in communities participating in an urban cancer screening program in China. Eligible participants will be adults aged 45 to 74 years who are permanent residents of participating communities and have been identified as being at high risk for at least one of five cancers: lung cancer, breast cancer, colorectal cancer, upper gastrointestinal cancer, or liver cancer. Participants must not have completed the corresponding free clinical screening before enrollment. This is a dual-cohort, cluster randomized controlled trial. Communities, rather than individual participants, will be assigned to one of three groups: a precision navigation group, a usual health education group, or a waiting control group. Part

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Aged 45 to 74 years. 2. Permanent resident of a participating community, defined as having lived in the community for at least 6 months during the past 12 months. 3. Participating in the urban cancer screening program. 4. Identified by the program risk assessment questionnaire as being at high risk for at least one of the following cancers: lung cancer, breast cancer, colorectal cancer, upper gastrointestinal cancer, or liver cancer. 5. Has not yet completed the corresponding free clinical screening test for the high-risk cancer type or types. 6. Able to complete electronic questionnaires and read intervention materials independently or with assistance. Paper materials and staff explanation will be provided for participants who do not use smartphones. 7. Able and willing to provide written informed consent. Exclusion Criteria: 1. Previously diagnosed with any of the target cancers, including lung cancer, breast cancer, colorectal cancer, upper gastrointestinal cancer, or liver cancer. 2. Severe cognitive impairment, severe mental illness, or other conditions that prevent the participant from receiving the intervention or completing study questionnaires. 3. Planning to be away from the community for a long period during the next 6 months, defined as cumulative absence of more than 3 months. 4. Currently participating in another interventional study that may affect cancer screening behavior.
๐Ÿ’Š

What it tests

  • Precision Navigation Intervention
  • Usual Health Education
๐Ÿ“

Where

3 sites
Huaihua Central Hospital (Huaihua Cancer Hospital)
Huaihua, China
Shaoyang Hospital of Traditional Chinese Medicine
Shaoyang, China
Yongzhou Central Hospital
Yongzhou, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy